KATHRYN BERNHARDT: Open Payments
NPI 1295233799 · PALM HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 61 payments from 16 companies in 2025. Trend: 2023 $1,321 · 2024 $1,966 · 2025 $1,513
Food & beverage: $1,433Education: $80
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $252 |
| ABBVIE INC. | 7 | $237 |
| Janssen Biotech, Inc. | 7 | $220 |
| GENZYME CORPORATION | 9 | $201 |
| Galderma Laboratories, L.P. | 10 | $167 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $82 |
| UCB, Inc. | 2 | $53 |
| Amgen Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $52 |
| LEO Pharma Inc. | 2 | $49 |
Products named: DUPIXENT, TREMFYA, RINVOQ, NEMLUVIO, SKYRIZI, Bimzelx, Otezla, TALTZ.
Industry payments across FL — which companies pay providers there.
